Cargando…
Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial
OBJECTIVE: There are no evidence-based practices for treating anxiety in patients with acute coronary syndrome (ACS). Thus, we investigated the effects of escitalopram on anxiety in this population. METHODS: We enrolled 217 patients with ACS who met Diagnostic and Statistical Manual of Mental Disord...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426500/ https://www.ncbi.nlm.nih.gov/pubmed/28449559 http://dx.doi.org/10.9758/cpn.2017.15.2.126 |
_version_ | 1783235491014901760 |
---|---|
author | Kang, Hee-Ju Bae, Kyung-Yeol Kim, Sung-Wan Shin, Il-Seon Hong, Young Joon Ahn, Youngkeun Jeong, Myung Ho Yoon, Jin-Sang Kim, Jae-Min |
author_facet | Kang, Hee-Ju Bae, Kyung-Yeol Kim, Sung-Wan Shin, Il-Seon Hong, Young Joon Ahn, Youngkeun Jeong, Myung Ho Yoon, Jin-Sang Kim, Jae-Min |
author_sort | Kang, Hee-Ju |
collection | PubMed |
description | OBJECTIVE: There are no evidence-based practices for treating anxiety in patients with acute coronary syndrome (ACS). Thus, we investigated the effects of escitalopram on anxiety in this population. METHODS: We enrolled 217 patients with ACS who met Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria for depressive disorders into a randomized double-blind placebo-controlled study. Patients received either escitalopram or placebo over a 24-week period. Anxiety symptoms were evaluated using the Hospital Anxiety and Depression Scale-anxiety subscale (HADS-A). A HADS-A score >7 was classified as an anxiety disorder. Baseline evaluations included sociodemographic and clinical characteristics, such as depressive symptoms, cardiovascular risk factors, and current cardiac status. RESULTS: Independent of improvements in depression and without any differences in safety profiles, escitalopram treatment was significantly more efficacious in treating and reducing anxiety than placebo over a 24-week period. CONCLUSION: Escitalopram can be recommended as an effective and safe treatment option for anxiety in patients with ACS. |
format | Online Article Text |
id | pubmed-5426500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Korean College of Neuropsychopharmacology |
record_format | MEDLINE/PubMed |
spelling | pubmed-54265002017-05-12 Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial Kang, Hee-Ju Bae, Kyung-Yeol Kim, Sung-Wan Shin, Il-Seon Hong, Young Joon Ahn, Youngkeun Jeong, Myung Ho Yoon, Jin-Sang Kim, Jae-Min Clin Psychopharmacol Neurosci Original Article OBJECTIVE: There are no evidence-based practices for treating anxiety in patients with acute coronary syndrome (ACS). Thus, we investigated the effects of escitalopram on anxiety in this population. METHODS: We enrolled 217 patients with ACS who met Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria for depressive disorders into a randomized double-blind placebo-controlled study. Patients received either escitalopram or placebo over a 24-week period. Anxiety symptoms were evaluated using the Hospital Anxiety and Depression Scale-anxiety subscale (HADS-A). A HADS-A score >7 was classified as an anxiety disorder. Baseline evaluations included sociodemographic and clinical characteristics, such as depressive symptoms, cardiovascular risk factors, and current cardiac status. RESULTS: Independent of improvements in depression and without any differences in safety profiles, escitalopram treatment was significantly more efficacious in treating and reducing anxiety than placebo over a 24-week period. CONCLUSION: Escitalopram can be recommended as an effective and safe treatment option for anxiety in patients with ACS. Korean College of Neuropsychopharmacology 2017-05 2017-05-31 /pmc/articles/PMC5426500/ /pubmed/28449559 http://dx.doi.org/10.9758/cpn.2017.15.2.126 Text en Copyright © 2017, Korean College of Neuropsychopharmacology This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kang, Hee-Ju Bae, Kyung-Yeol Kim, Sung-Wan Shin, Il-Seon Hong, Young Joon Ahn, Youngkeun Jeong, Myung Ho Yoon, Jin-Sang Kim, Jae-Min Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial |
title | Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial |
title_full | Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial |
title_fullStr | Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial |
title_full_unstemmed | Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial |
title_short | Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial |
title_sort | effects of escitalopram on anxiety in patients with acute coronary syndrome: a randomized controlled trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426500/ https://www.ncbi.nlm.nih.gov/pubmed/28449559 http://dx.doi.org/10.9758/cpn.2017.15.2.126 |
work_keys_str_mv | AT kangheeju effectsofescitalopramonanxietyinpatientswithacutecoronarysyndromearandomizedcontrolledtrial AT baekyungyeol effectsofescitalopramonanxietyinpatientswithacutecoronarysyndromearandomizedcontrolledtrial AT kimsungwan effectsofescitalopramonanxietyinpatientswithacutecoronarysyndromearandomizedcontrolledtrial AT shinilseon effectsofescitalopramonanxietyinpatientswithacutecoronarysyndromearandomizedcontrolledtrial AT hongyoungjoon effectsofescitalopramonanxietyinpatientswithacutecoronarysyndromearandomizedcontrolledtrial AT ahnyoungkeun effectsofescitalopramonanxietyinpatientswithacutecoronarysyndromearandomizedcontrolledtrial AT jeongmyungho effectsofescitalopramonanxietyinpatientswithacutecoronarysyndromearandomizedcontrolledtrial AT yoonjinsang effectsofescitalopramonanxietyinpatientswithacutecoronarysyndromearandomizedcontrolledtrial AT kimjaemin effectsofescitalopramonanxietyinpatientswithacutecoronarysyndromearandomizedcontrolledtrial |